Areteia Therapeutics Employee Directory
Biotechnology ResearchNorth Carolina, United States2-10 Employees
Areteia Therapeutics is a small biotechnology company based in Lake Park, North Carolina, focused on developing treatments for asthma. It pursued an oral therapy for eosinophilic asthma, aiming to give patients greater control over their condition and daily lives, with the goal of being the first oral treatment for this form of asthma, including a candidate known as oral dexpramipexole. In 2025, governance changes took place, with Donald J. Hayden, Jr. named as Chair of the Board and Ian F. Smith appointed as Chair of the Audit Committee. In November 2025 the company began winding down, and the corporate page was maintained for historical employment verification. Earlier in 2025, Areteia Therapeutics participated in the J.P. Morgan Healthcare Conference, reflecting ongoing engagement with the biotech community.